Last update 05 Sep 2026

Compound 7n (Nanjing University of Chinese Medicine)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
IL-1β
Action
inhibitors
Mechanism
IL-1β inhibitors(Interleukin-1 beta inhibitors)
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal Diseases
Active Indication
Osteoarthritis
Inactive Indication-
Originator Organization
Nanjing University of Chinese MedicineNanjing University of Chinese MedicineShanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
Active Organization
Nanjing University of Chinese MedicineNanjing University of Chinese MedicineShanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC33H49BrN2O2
InChIKeyQPIQQCBHSCUOIM-CEJXBKOESA-N
CAS Registry2923086-26-2

Related

100 Clinical Results associated with Compound 7n (Nanjing University of Chinese Medicine)
Login to view more data
100 Translational Medicine associated with Compound 7n (Nanjing University of Chinese Medicine)
Login to view more data
100 Patents (Medical) associated with Compound 7n (Nanjing University of Chinese Medicine)
Login to view more data
100 Deals associated with Compound 7n (Nanjing University of Chinese Medicine)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
OsteoarthritisPreclinical
China
Nanjing University of Chinese MedicineNanjing University of Chinese Medicine
20 Jan 2023
OsteoarthritisPreclinical
China
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
20 Jan 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free